Marlene Moster, MD
Ophthalmology · Sunrise, FLNPI 1962475806
Payments from drug & device makers
Across 770 payments — averaging $1074.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$506K
- Bausch & Lomb Americas Inc.$129K
- Aerie Pharmaceuticals, Inc.$64K
- Glaukos Corporation$39K
- Bausch & Lomb, A Division Of Bausch Health US, LLC$38K
- Alcon$23K
- plus $29K from 25 others
Across 1 payment — averaging $81.35 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- AbbVie$81
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 292 | $505,736 |
| Bausch & Lomb Americas Inc. | 152 | $128,807 |
| Aerie Pharmaceuticals, Inc. | 82 | $64,094 |
| Glaukos Corporation | 28 | $39,184 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 56 | $37,823 |
| Alcon | 54 | $22,505 |
| Thea Pharma Inc. | 7 | $9,585 |
| W. L. Gore & Associates, Inc. | 14 | $7,994 |
| Regeneron | 2 | $2,529 |
| Novartis | 17 | $2,386 |
| Alcon Research LLC | 3 | $2,006 |
| Sight Sciences, Inc. | 19 | $1,080 |
| Iridex Corporation | 4 | $957 |
| Mobius Therapeutics, LLC | 5 | $500 |
| NEW World Medical,inc. | 8 | $499 |
| Ivantis, Inc | 3 | $408 |
| Amgen(2 entities) | 3 | $335 |
| Sanofi | 1 | $137 |
| Biogen | 1 | $121 |
| Ellexiscience | 1 | $106 |
| Argenx US, Inc. | 1 | $98 |
| Sun Pharmaceutical Industries Inc. | 5 | $93 |
| Lumibird Medical Inc. | 1 | $53 |
| Akorn, Inc. | 2 | $37 |
| Oyster Point Pharma, Inc. | 1 | $31 |
| Harrow Eye, LLC | 1 | $23 |
| Carl Zeiss Meditec AG | 1 | $19 |
| Omeros Corporation | 1 | $15 |
| Kala Pharmaceuticals, Inc. | 1 | $14 |
| Eyepoint US, Inc. | 1 | $12 |
| Rapid Pathogen Screening, Inc. | 3 | $0 |
How this compares
$827,189 in reported general payments places this provider in the 95th percentile of 1,405 ophthalmology providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other ophthalmology in Sunrise
- David EichenbaumSt Petersburg$34.4M
- Robert RadenDelray Beach$7.8M
- Carl DanzigPompano Beach$5.3M
- Bruce SegalDelray Beach$4.7M
- Cathleen McCabeBradenton$4.6M
- Ivan SunerTampa$3.7M
- Sunir JoshiFt Lauderdale$3.7M
- Harold BrooksTallahassee$3.5M
- Matthew CunninghamOrlando$2.9M
- Benjamin ThomasJacksonville$2.8M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.